Loading insider details...
Beta
Latest Form 4 (Jun 18, 2026): Exercise/Conversion of 219 BTAI shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 18, 2026 | BioXcel Therapeutics, Inc. (BTAI) | Exercise/Conversion | 219 | n/a |
| May 22, 2026 | BioXcel Therapeutics, Inc. (BTAI) | Exercise/Conversion | 49,758 | n/a |
| May 7, 2026 | BioXcel Therapeutics, Inc. (BTAI) | Exercise/Conversion | 18,000 | n/a |
| Mar 17, 2026 | BioXcel Therapeutics, Inc. (BTAI) | Exercise/Conversion | 164 | n/a |
| Jan 6, 2026 | BioXcel Therapeutics, Inc. (BTAI) | Grant/Award | 199,032 | n/a |
| Dec 16, 2025 | BioXcel Therapeutics, Inc. (BTAI) | Exercise/Conversion | 164 | n/a |
| Sep 16, 2025 | BioXcel Therapeutics, Inc. (BTAI) | Exercise/Conversion | 163 | n/a |
| Aug 6, 2025 | BioXcel Therapeutics, Inc. (BTAI) | Grant/Award | 18,000 | n/a |
| Jul 23, 2025 | BioXcel Therapeutics, Inc. (BTAI) | Grant/Award | 15,625 | n/a |
| Jun 16, 2025 | BioXcel Therapeutics, Inc. (BTAI) | Exercise/Conversion | 163 | n/a |